SavedAdd your journal

Journals / Anatomy / 2015 / Cilt: 9 - Sayı: 3

EFFECTS OF SINGLE-DOSE KETAMINE INFUSION ON BEHAVIORAL PARAMETERS AND NEURONAL ACTIVATION IN THE MEDIAL PREFRONTAL CORTEX OF JUVENILE RATS EXPOSED TO PRENATAL STRESS

ELİF POLAT ÇORUMLU
Osman Özcan AYDIN
Emine AYDIN GÜLHAN
EMEL ULUPINAR
Journal
Anatomy
Pages
142–150
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Two-way ANOVA test results showed significant differences among groups and a group X gender interaction in the density of c-Fos expressing neurons present in the medial prefrontal cortex.Conclusion: A single-dose ketamine treatment might differentially affect the depressive-like behaviors of juvenile animals exposed to prenatal stress and activate neurons in the medial prefrontal cortical region in a gender-dependent manner.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Subanesthetic dose of ketamine administration produces antidepressant-like response especially in treatmentresistant depression patients.
📊
Key Findings & Data:Ketamine’s rapid and sustained actions have also been demonstrated in normal or chronically stressed animals, but no experimental studies have examined its effects in prenatally stressed rodents.
💡
Conclusion & Impact:Two-way ANOVA test results showed significant differences among groups and a group X gender interaction in the density of c-Fos expressing neurons present in the medial prefrontal cortex.Conclusion: A single-dose ketamine treatment might differentially affect the depressive-like behaviors of juvenile animals exposed to prenatal stress and activate neurons in the medial prefrontal cortical region in a gender-dependent manner.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:c-Fos · depression · ketamine

Abstract

Objectives: Subanesthetic dose of ketamine administration produces antidepressant-like response especially in treatmentresistant depression patients. Ketamine’s rapid and sustained actions have also been demonstrated in normal or chronically stressed animals, but no experimental studies have examined its effects in prenatally stressed rodents. Therefore, aim of thepresent study was to investigate the behavioral and structural consequences of single-dose ketamine application in juvenile rats exposed to prenatal stress.Methods: Prenatal stress protocol was applied by immobilization of pregnant rats during the last week of their gestation for 3 hours a day. While treatment group received a single-dose (10 mg/kg) of intraperitoneal ketamine injection, control and stress groups received same amount of saline injections at P38. After completion of behavioral tests (sucrose preference, modified grip and forced swim), animals were sacrificed via intracardiac perfusion. Then, immediate gene expression in the medial prefrontal cortex was evaluated by c-Fos immunohistochemistry.Results: Although the active coping and depressive-like behavior of juvenile animals exposed to prenatal stress did not significantly change, ketamine application caused alterations in the sucrose preference pattern of animals and immobility time in the forced swim test. Two-way ANOVA test results showed significant differences among groups and a group X gender interaction in the density of c-Fos expressing neurons present in the medial prefrontal cortex.Conclusion: A single-dose ketamine treatment might differentially affect the depressive-like behaviors of juvenile animals exposed to prenatal stress and activate neurons in the medial prefrontal cortical region in a gender-dependent manner.

🔖

Cite This Article

ÇORUMLU, E. P., AYDIN, O. Ö., GÜLHAN, E. A., ULUPINAR, E. (2015). EFFECTS OF SINGLE-DOSE KETAMINE INFUSION ON BEHAVIORAL PARAMETERS AND NEURONAL ACTIVATION IN THE MEDIAL PREFRONTAL CORTEX OF JUVENILE RATS EXPOSED TO PRENATAL STRESS. Anatomy, Cilt: 9 - Sayı: 3, 142–150. https://ajindex.com/articles/150817

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. World Health Organization. The world health report 2001 – Mental Health: new understanding, new hope. Geneva: WHO; 2001.
  2. Andrade L, Caraveo-A. Epidemiology of major depressive episodes: Results from the international consortium of psychiatric epidemiology (ICPE) surveys. Int J Methods Psychiatr Res 2003; 12:3–21.
  3. Gray AL, Hyde TM, Deep-Soboslay A, Kleinman JE, Sodhi MS. Sex differences in glutamate receptor gene expression in major depression and suicide. MS Mol Psychiatry 2015;20:1057–68.
  4. Katz MM, Tekell JL, Bowden CL, Brannan S. Houston JP, Bermann N, Frazer A. Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression. Neuropsychopharmacology 2004;29:566–79. Gagné GG Jr, Furman MJ, Carpenter LL, Price LH. Efficacy of continuation ECT and antidepressant drugs compared to longterm antidepressants alone in depressed patients. Am J Psychiatry;157:1960–5.
  5. Duman RS, Li N, Liu RJ, Duric V, Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012;62:35–41.
  6. M aan het Rot, CA Zarate Jr, DS Charney, SJ. Ketamine for depression: where do we go from here? Biol Psychiatry 2012;72: 537–47.
  7. Murrough JW, Losifescu VD, Chang LC. antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013; 170:1134-42.
  8. Price BR, Losifescu VD, Murrough JW. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression. Depress Anxiety 2014;31: 335–43.
  9. Romeo B, Choucha W, Fossati P, Rotge JY. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Res 2015;230:682–88.
  10. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H, Li XY, Aghajanian G, Duman RS. Glutamate NMDA receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011;69:754–61.
  11. Heller AS, Johnstone T, Peterson MJ, Kolden GG, Kalin NH, Davidson RJ. Increased prefrontal cortex activity during negative emotion regulation as a predictor of depression symptom severity trajectory over 6 months. JAMA Psychiatry 2013;70:1181–9.
  12. Kang HJ, Voleti B, Hajszan T, Rajkowska G, Stockmeier CA, Licznerski P, Lepack A, Majik MS, Jeong LS, Banasr M, Son H, Duman RS. Decreased expression of synapse-related genes and loss of synapses in major depressive disorder. Nat Med 2012;18:1413–7.
  13. Grimm S, Lubor